Lemaitre Vascular (LMAT) Other Operating Expenses (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Other Operating Expenses data on file, last reported at $14.5 million in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $14.5 million, up 2.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $54.8 million (up 11.17% YoY), and the FY2025 annual result was $54.5 million, up 16.53% from the prior year.
• Other Operating Expenses rose to $14.5 million in Q1 2026 per LMAT's latest filing, from $13.4 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $14.9 million in Q2 2025 and troughed at $7.8 million in Q1 2022.
• A 5-year average of $11.4 million and a median of $11.3 million in 2022 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2022 and 2023: Other Operating Expenses jumped 199.05% in 2022, then fell 8.4% in 2023.
• A 5-year view of Other Operating Expenses shows it stood at $8.6 million in 2022, then increased by 19.4% to $10.3 million in 2023, then increased by 22.96% to $12.6 million in 2024, then climbed by 6.4% to $13.4 million in 2025, then advanced by 8.05% to $14.5 million in 2026.
• Business Quant data shows LMAT's Other Operating Expenses at $14.5 million in Q1 2026, $13.4 million in Q4 2025, and $11.9 million in Q3 2025.